Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Clinical Trial for the Evaluation of the Efficacy of Transanal Total Mesorectal Excision

NCT02406118 is registered in ClinicalTrials.gov with National Cancer Center, Korea as lead sponsor.

NCT NCT02406118
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02406118 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Clinical Trial for the Evaluation of the Efficacy of Transanal Total Mesorectal Excision
Lead sponsor
National Cancer Center, Korea
Phase
Not applicable
Overall status
Unknown status
Start date
March 1, 2015
Completion date
December 1, 2022
Enrollment
49 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer